Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3097-3117
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3097
Figure 5
Figure 5 Nomogram combining glycolysis-related risk score and clinicopathological parameters for predicting gastric cancer patients’ survival. A: Construction of a nomogram including age, gender, grade, stage, T, N, M and risk score to predict 3- and 5-year overall survival (OS); B and C: A greement between predicted and observed 3- and 5-year OS. Dashed line indicated ideal performance. The actual performances were indicated by blue line (3-year OS) (B) and red line (5-year OS) (C); D: Merged results. OS: Overall survival.